Crown Laboratories
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 349 Lafe Cox Drive, Johnson City, Tennessee (TN) 37604-7469, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 1019820 · DUNS 119508400
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-09-19
- NAIDrug Quality Assurance2018-03-15
- NAIBioresearch Monitoring2018-02-15
- VAIBioresearch Monitoring2016-04-08
- OAIUnapproved and Misbranded Drugs2014-09-24
- OAIUnapproved and Misbranded Drugs2014-02-14
- VAIDrug Quality Assurance2014-02-14
- VAIDrug Quality Assurance2012-03-09
- VAIDrug Quality Assurance2011-11-03
Drugs this plant is listed as making
4 distinct drugs across 9 products name this site in their FDA label.
- HydrocortisoneCrown Laboratories
- Nystatin and Triamcinolone AcetonideCrown Laboratories
- Nystatin CreamCrown Laboratories
- Triamcinolone AcetonideCrown Laboratories
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.